This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Legrand, O., Simonin, G., Zittoun, R. et al. Both P-gp and MRP contribute to drug resistance in AML. Leukemia 12, 1327–1328 (1998). https://doi.org/10.1038/sj.leu.2401096
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401096
This article is cited by
-
Probenecid is a chemosensitizer in cancer cell lines
Cancer Chemotherapy and Pharmacology (2012)
-
The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cells
Cancer Chemotherapy and Pharmacology (2009)
-
MDR1 expression in poor-risk acute myeloid leukemia with partial or complete monosomy 7
Leukemia (2001)
-
Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implications
Oncogene (2000)
-
Diagnostics of multidrug resistance in cancer
Pathology & Oncology Research (1998)